This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the market for bone densitometers (including DXA, QUS, QCT, RA, and SXA systems) and bone turnover marker tests for the US, the five major EU markets, Japan, and the rest of world markets.
BONE DENSITOMETERS and BONE TURNOVER MARKER TESTS MARKET HIGHLIGHTS
KEY QUESTIONS ANSWERED
Executive Summary i. Market analysis a. Selected market drivers and limiters b. Market leaders ii. Methodology Exhibit ES-1: Bone densitometry systems and bone turnover marker tests, combined market forecast, by segment ($m), 2017-23 Exhibit ES-2: Bone densitometry systems and bone turnover marker tests, combined market forecast, by region ($m), 2017-23 1. Overview of Osteoporosis 1.1 Prevalence 1.2 Fracture incidence and economic costs 1.3 Types of osteoporosis 1.4 Risk factors 1.5 Treatment 1.6 Bibliography Exhibit 1-1: Osteoporosis prevalence rate, per 10,000 population, US Exhibit 1-2: Osteoporosis prevalence, five major EU markets Exhibit 1-3: Osteoporosis prevalence, Japan Exhibit 1-4: Osteoporosis-caused fracture incidence in the EU, by fracture site Exhibit 1-5: Number of visits for osteoporotic fractures (in 000s), US Exhibit 1-6: Types of osteoporosis and their primary causes and fracture types Exhibit 1-7: Leading risk factors for osteoporosis Exhibit 1-8: Population growth of 65+ years age group, selected countries, 2000-50 2. Bone Densitometry Products Market 2.1 Bone densitometry overview 2.1.1 Dual-energy X-ray absorptiometry 2.1.2 Single-energy X-ray absorptiometry 2.1.3 Radiographic absorptiometry 2.1.4 Quantitative computed tomography 2.1.5 Quantitative ultrasound 2.1.6 Software-based densitometry systems 2.1.7 Hospital-based densitometry systems 2.1.8 Office-based densitometry systems 2.2 Densitometry products 2.2.1 BeamMed 2.2.2 CompuMed 2.2.3 Furuno Electric Company 2.2.4 GE Healthcare/General Electric Company 2.2.5 Hologic 2.2.6 Swissray 2.2.7 Emerging company 2.3 Market analysis 2.3.1 Market forecast: US 2.3.2 Market forecast: EU 2.3.3 Market forecast: Japan 2.3.4 Market forecast: rest of the world 2.3.5 Competitive analysis: global 2.4 Primary research 2.5 Bibliography Exhibit 2-1: Comparison of biochemical markers and bone densitometry for diagnosing and monitoring osteoporosis Exhibit 2-2: Imaging modalities used to diagnose osteoporosis Exhibit 2-3: Selected bone densitometry systems Exhibit 2-4: DXA price range, US Exhibit 2-5: The Lunar iDXA dual-energy X-ray absorptiometry system Exhibit 2-6: The Horizon dual-energy X-ray absorptiometry system Exhibit 2-7: Bone densitometry systems market forecast, by region, 2017-23 Exhibit 2-8: Bone densitometry systems global market, share by supplier, 2017 Exhibit 2-9: Bone densitometry systems US market, share by supplier, 2017 Exhibit 2-10: Bone densitometry systems five major EU markets, share by supplier, 2017 Exhibit 2-11: Bone densitometry systems Japan market, share by supplier, 2017 Exhibit 2-12: Bone densitometry systems RoW market, share by supplier, 2017 Exhibit 2-13: Meddevicetracker survey: percentage of bone density scans performed to screen for osteoporosis, 2018 Exhibit 2-14: Meddevicetracker survey: How did the number of bone density scans you performed or referred in 2018 compare to 2017? Exhibit 2-15: Meddevicetracker survey: type of bone densitometry system used, as a percentage of total bone scans 3. Market for Bone Turnover Marker Tests 3.1 Biochemical markers overview 3.1.1 Types of bone turnover markers 3.1.2 Applications 3.1.3 Limitations 3.2 Bone turnover marker testing products 3.2.1 Alere/Abbott 3.2.2 Beckman Coulter/Danaher 3.2.3 Immunodiagnostic Systems 3.2.4 Orion Diagnostica/Orion Group 3.2.5 Quest Diagnostics 3.2.6 Quidel 3.2.7 Roche Diagnostics/F. Hoffmann-La Roche 3.3 Reimbursement 3.4 Market analysis 3.5 Competitive analysis 3.6 Primary research 3.7 Bibliography Exhibit 3-1: The bone remodeling cycle Exhibit 3-2: Comparison of the types of bone turnover marker tests Exhibit 3-3: Selected bone turnover marker tests Exhibit 3-4: Bone turnover marker tests market forecast, by region, 2017-23 Exhibit 3-5: Bone turnover marker tests global market, share by supplier, 2017 Exhibit 3-6: Meddevicetracker survey: How effective do you consider bone turnover marker tests for identifying patients at high risk of osteoporosis? Exhibit 3-7: Meddevicetracker survey: How effective do you consider bone turnover marker tests for monitoring treatment for osteoporosis? APPENDIX: COMPANY LISTING